Engineering multifunctional nanoparticles: all-in-one versus one-for-all

被引:80
作者
Huynh, Elizabeth [1 ,2 ]
Zheng, Gang [1 ,2 ]
机构
[1] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[2] Univ Hlth Network, Ontario Canc Inst, Techna Inst, Toronto, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
IRON-OXIDE NANOPARTICLES; PEGYLATED LIPOSOMAL DOXORUBICIN; LONG-CIRCULATING NANOPARTICLES; GOLD NANOPARTICLES; CANCER-THERAPY; SOLID TUMORS; MAGNETIC NANOPARTICLES; BIOMEDICAL APPLICATIONS; CONTRAST AGENT; QUANTUM DOTS;
D O I
10.1002/wnan.1217
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Multifunctional nanoparticles have been developed to overcome the conventional hurdles associated with the diagnosis and treatment of disease. However, there are often caveats involved with the development and clinical translation of multifunctional nanoparticles largely regarding the notion that additional functionality increases nanoparticle complexity. Here, we discuss two design concepts, a conventional approach, all-in-one', and introduce the concept of one-for-all' to suggest that multifunctionality does not necessarily result in multicomponent complex nanoparticles. This review focuses on the design concepts of all-in-one and one-for-all with examples of each approach and a discussion on the implications for clinical translation. WIREs Nanomed Nanobiotechnol 2013, 5:250265. doi: 10.1002/wnan.1217 For further resources related to this article, please visit the WIREs website.
引用
收藏
页码:250 / 265
页数:16
相关论文
共 99 条
  • [11] Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
    Choi, Chung Hang J.
    Alabi, Christopher A.
    Webster, Paul
    Davis, Mark E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (03) : 1235 - 1240
  • [12] Renal clearance of quantum dots
    Choi, Hak Soo
    Liu, Wenhao
    Misra, Preeti
    Tanaka, Eiichi
    Zimmer, John P.
    Ipe, Binil Itty
    Bawendi, Moungi G.
    Frangioni, John V.
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (10) : 1165 - 1170
  • [13] Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes
    Choi, Jong Hyun
    Nguyen, Freddy T.
    Barone, Paul W.
    Heller, Daniel A.
    Moll, Anthonie E.
    Patel, Dhaval
    Boppart, Stephen A.
    Strano, Michael S.
    [J]. NANO LETTERS, 2007, 7 (04) : 861 - 867
  • [14] To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
    Danhier, Fabienne
    Feron, Olivier
    Preat, Veronique
    [J]. JOURNAL OF CONTROLLED RELEASE, 2010, 148 (02) : 135 - 146
  • [15] Carbon nanotubes as photoacoustic molecular imaging agents in living mice
    De La Zerda, Adam
    Zavaleta, Cristina
    Keren, Shay
    Vaithilingam, Srikant
    Bodapati, Sunil
    Liu, Zhuang
    Levi, Jelena
    Smith, Bryan R.
    Ma, Te-Jen
    Oralkan, Omer
    Cheng, Zhen
    Chen, Xiaoyuan
    Dai, Hongjie
    Khuri-Yakub, Butrus T.
    Gambhir, Sanjiv S.
    [J]. NATURE NANOTECHNOLOGY, 2008, 3 (09) : 557 - 562
  • [16] Synthesis of 64CuII-Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In Vivo Evaluation as Dual-Modality PET-MRI Agent
    de Rosales, Rafael Torres Martin
    Tavare, Richard
    Paul, Rowena L.
    Jauregui-Osoro, Maite
    Protti, Andrea
    Glaria, Arnaud
    Varma, Gopal
    Szanda, Istvan
    Blower, Philip J.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (24) : 5509 - 5513
  • [17] Liposomes for photodynamic therapy
    Derycke, ASL
    de Witte, PAM
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (01) : 17 - 30
  • [18] Biocompatible Magnetofluorescent Probes: Luminescent Silicon Quantum Dots Coupled with Superparamagnetic Iron(III) Oxide
    Erogbogbo, Folarin
    Yong, Ken-Tye
    Hu, Rui
    Law, Wing-Cheung
    Ding, Hong
    Chang, Ching-Wen
    Prasad, Paras N.
    Swihart, Mark T.
    [J]. ACS NANO, 2010, 4 (09) : 5131 - 5138
  • [19] GABIZON A, 1994, CANCER RES, V54, P987
  • [20] Polyethylene glycol coated (pegylated) liposomal doxorubicin - Rationale for use in solid tumours
    Gabizon, A
    Martin, F
    [J]. DRUGS, 1997, 54 (Suppl 4) : 15 - 21